Powder: -20°C for 3 years | In solvent: -80°C for 1 year
TP-5801 TFA is an orally active inhibitor of TNK1, a non-receptor tyrosine kinase, with an IC50 value of 1.40 nM, demonstrating anti-tumor activity [1].
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
5 mg | Inquiry | Inquiry | |
50 mg | Inquiry | Inquiry |
Description | TP-5801 TFA is an orally active inhibitor of TNK1, a non-receptor tyrosine kinase, with an IC50 value of 1.40 nM, demonstrating anti-tumor activity [1]. |
In vitro | TP-5801 (10 pM-10 μM; 72 h) TFA treatment inhibits the growth of Ba/F3 cells driven by TNK1, BCR-ABL, and IL-3 [1]. Additionally, TP-5801 (1 nM-10 μM; 10 d) TFA suppresses the growth of TNK1-dependent L540 cells [1]. |
In vivo | TP-5801, administered via oral gavage at a dose of 10 mg/kg in a single administration, has been shown to be effective in a murine tumor survival model [1]. Moreover, when given at a dose of 50 mg/kg once daily for 7 days, TP-5801 consistently inhibited local tumor growth [1]. |
Molecular Weight | 641.48 |
Formula | C26H32BrF3N8O3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
TP-5801 TFA Others inhibitor inhibit